Genomix Molecular Diagnostics Private Limited - Company Profile

It is a life sciences private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Genomix Molecular Diagnostics Private Limited

Genomix Molecular Diagnostics Private Limited, a active private limited company, was established on 03 January 2007 in Hyderabad, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U85110TG2007PTC052224. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.52 M.

It upholds a compliant status. Employing 7 professional, Its leadership includes Vijay Kumar Kanthamneni (Director), Rathnagiri Polavarapu (Director), Bilhan Kavikishore Polavarapu (Director). Past directors included Krishnakishore Kota, Bilhan Kavikishore Polavarapu, Ojasvi Polavarapu. It holds ₹2.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No.5-36/207, Prashanth Nagar, Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110TG2007PTC052224

  • Registration Number

    052224

  • Incorporation Date

    03 January 2007

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.52 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.52 M
  • Company Age 19 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.90 M
  • Revenue Growth **** -9.34%
  • Profit Growth **** 79.93%
  • Ebitda **** -33.82%
  • Net Worth -1.61%
  • Total Assets -27.54%
Company report

Genomix Molecular Diagnostics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genomix Molecular Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genomix Molecular Diagnostics Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Kumar Kanthamneni Director 03 Jan 2007 Current
Rathnagiri Polavarapu Director 03 Jan 2007 Current
Bilhan Kavikishore Polavarapu Director 18 Aug 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Feb 2019 Past
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Director 28 Feb 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genomix Molecular Diagnostics.

Genomix Molecular Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.34% decrease. The company also saw a substantial improvement in profitability, with a 79.93% increase in profit. The company's net worth dipped by a decrease of 1.61%.

Genomix Molecular Diagnostics revenue growth over time
Genomix Molecular Diagnostics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -9.34%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.99%
*******
*******
*******
*******
Total Assets
*******
 -27.54%
*******
*******
*******
*******
Profit or Loss
*******
 79.93%
*******
*******
*******
*******
Net Worth
*******
 -1.61%
*******
*******
*******
*******
EBITDA
*******
 -33.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genomix Molecular Diagnostics?

In 2023, Genomix Molecular Diagnostics had a public holding of 2.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Department Of Biotechnology : 0.29 Cr
Latest Charge Details
Date Lender Amount Status
07 Sep 2009 Department Of Biotechnology ₹2.90 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Genomix Molecular Diagnostics?

Genomix Molecular Diagnostics has a workforce of 7 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genomix Molecular Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Molecular Diagnostics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genomix Molecular Diagnostics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Genomix Molecular Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Genomix Molecular Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Bilhan Kavikishore Polavarapu was appointed as a Director was appointed as a Director on 18 Aug 2021 & has been associated with this company since 4 years 6 months . was completed.

  • Charges

    Progress on A charge with Department Of Biotechnology amounted to Rs. 2.90 M with Charge ID 10175699 was registered on 07 Sep 2009. was documented.

  • Director Appointment

    Progress on Vijay Kumar Kanthamneni was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 19 years 1 month . was documented.

  • Director Appointment

    Rathnagiri Polavarapu was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 19 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genomix Molecular Diagnostics Private Limited?

The CIN of Genomix Molecular Diagnostics Private Limited is U85110TG2007PTC052224.

Where is Genomix Molecular Diagnostics Private Limited headquartered?

Genomix Molecular Diagnostics Private Limited is headquartered at D.No.5-36/207, Prashanth Nagar, Kukatpally, Hyderabad, Telangana, 500072.

When was Genomix Molecular Diagnostics Private Limited incorporated?

Genomix Molecular Diagnostics Private Limited was incorporated on 03 January 2007.

Who are the current directors of Genomix Molecular Diagnostics Private Limited?

The current directors of Genomix Molecular Diagnostics Private Limited are

What is the primary industry of Genomix Molecular Diagnostics Private Limited?

The primary industry of Genomix Molecular Diagnostics Private Limited is Professional, Scientific And Technical.

Is Genomix Molecular Diagnostics Private Limited a listed company?

Genomix Molecular Diagnostics Private Limited is unlisted.

What is the capital structure of Genomix Molecular Diagnostics Private Limited?

The authorized capital of Genomix Molecular Diagnostics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.52 M.

What is the compliance status of Genomix Molecular Diagnostics Private Limited?

The compliance status of Genomix Molecular Diagnostics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available